Follow The Filings

ELV Elevance Health

Health Care, filed as ELEVANCE HEALTH INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 4 managers in 2026 Q2, sold by 5

  • 1 Owner
  • #36
  • Max 0.0%
  • Master 0.44%
  • $16K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.01%

Who owns ELV

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 40 $16K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ELV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ELV insider trades
  • $2.2M bought by 3 insiders
  • $6.4M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mark Kaye CFO
    Sale
    $4.7M 10,584 shares at $440.13 35% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  2. Gail Boudreaux CEO
    Buy
    $1M 2,725 shares at $367.79 +1.6% to stake
    Traded Jul 17 Filed Jul 17
    ↗
  3. Ramiro G Peru Director
    Buy
    $366K 1,000 shares at $366.05 +10% to stake
    Traded Jul 17 Filed Jul 17
    ↗
  4. Ronald W Penczek CAO & Controller
    Sale
    $149K 369 shares at $403.16 9% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  5. Robert L Dixon Jr. Director
    Sale
    $61K 151 shares at $401.77 1.4% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  6. Ronald W Penczek CAO & Controller
    Sale
    $617K 1,531 shares at $403.13 27% of stake
    Traded May 19 Filed May 20
    ↗
  7. Amy W Schulman Director
    Sale
    $7,475 26 shares at $287.50 11% of stake
    Traded Mar 12 Filed Mar 23
    ↗
  8. Charles Morgan Kendrick Jr. EVP & President, Commercial
    Sale
    $911K 3,196 shares at $284.92 21% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  9. Steven H Collis Director
    Buy
    $870K 3,000 shares at $289.84 +470% to stake
    Traded Mar 5 Filed Mar 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 22 share withholdings for taxes, and 2 option exercises.

Congress

11 members of Congress traded ELV in the last three years: 17 buys and 12 sales. 7 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Markwayne Mullin R-OKJoint Buy $15K–$50K Dec 29, 2025 filed Jan 16
  3. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Aug 13, 2025 filed Sep 12, 2025
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Aug 5, 2025 filed Sep 12, 2025
  5. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Jan 13, 2025 filed Sep 12, 2025
  6. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $171.34B $177.01B $199.12B
Gross profit * $154.05B $157.26B $177.95B
Gross margin * 89.9% 88.8% 89.4%
Net income $5.99B $5.98B $5.66B
Net margin * 3.5% 3.4% 2.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $60.03B $58.94B $63B
Total non-current assets * $48.9B $57.95B $58.49B
Total assets $108.93B $116.89B $121.49B
Total current liabilities $41.79B $40.58B $41.04B
Total non-current liabilities * $27.73B $34.88B $36.43B
Total equity $39.31B $41.32B $43.88B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.06B $5.81B $4.29B
Cash from investing -$5.57B -$5.17B -$1.34B
Cash from financing -$3.35B $1.19B -$1.74B
Net change in cash -$0.861B $1.83B $1.2B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.